IFP Advisors’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154K Sell
4,884
-316
-6% -$9.74K ﹤0.01% 1694
2026
Q1
$149K Buy
5,200
+4,833
+1,317% +$141K ﹤0.01% 1562
2025
Q4
$10.4K Hold
367
﹤0.01% 3046
2025
Q3
$10.3K Hold
367
﹤0.01% 2892
2025
Q2
$9.64K Buy
+367
New +$9.1K ﹤0.01% 2944

Other funds holding REVS

IFP Advisors's REVS Position: Q2 2026 in Review

IFP Advisors reduced its Columbia Research Enhanced Value ETF (REVS) stake by 6.1% in Q2 2026, selling an estimated $9.74K and leaving 4,884 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

IFP Advisors first reported a position in REVS in Q2 2025 and has held it in 5 quarters since. 4 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • IFP Advisors held 4,884 shares of Columbia Research Enhanced Value ETF worth $154K as of Q2 2026.
  • IFP Advisors sold 316 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $9.74K.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1694 holding.
  • IFP Advisors first reported a position in Columbia Research Enhanced Value ETF in Q2 2025 and has held it in 5 quarters since.
  • 4 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.